Back to News
Market Impact: 0.6

Wall St set for lower open after rally, Trump's visa crackdown weighs

MSFTAMZNCTSHJPMINTCSPYQQQIWMKVUEPFEMTSRCOMPHOUSFOXAFOX
Market Technicals & FlowsInvestor Sentiment & PositioningMonetary PolicyInterest Rates & YieldsRegulation & LegislationTechnology & InnovationM&A & RestructuringHealthcare & Biotech
Wall St set for lower open after rally, Trump's visa crackdown weighs

Wall Street futures indicated a lower open, pausing a tech-driven rally, as new Trump administration H-1B visa policies proposing a $100,000 annual fee sparked concerns for major tech and financial firms heavily reliant on skilled foreign workers, leading to pre-market declines in megacaps like Microsoft and Amazon. This market shift follows recent record highs fueled by anticipated Fed rate cuts and AI enthusiasm, with investors now awaiting key economic data including PCE and GDP, alongside comments from Fed policymakers.

Analysis

U.S. equity markets are signaling a cautious open, retreating from recent record highs as new regulatory headwinds emerge for the technology sector. The Trump administration's proposal to impose a $100,000 annual fee for H-1B visas is creating pre-market pressure on tech megacaps like Microsoft and Amazon, as well as on major visa sponsors such as Cognizant, JPMorgan, and Intel, which saw declines between 0.5% and 1.6%. A J.P. Morgan analyst note characterized the policy as creating an 'incrementally stringent' environment, suggesting companies will take actions to mitigate the financial impact. This pullback follows a strong rally, fueled by revived AI enthusiasm and expectations of Fed rate cuts, which had pushed the S&P 500 and Nasdaq to their third consecutive week of gains. Futures indicate a broad-based decline, with S&P 500 E-minis down 0.34% and Nasdaq 100 E-minis down 0.39%. Beyond the tech-sector concerns, significant single-stock movements are being driven by M&A and company-specific news. Pfizer's stock rose 1.7% on its planned acquisition of weight-loss drug developer Metsera, whose shares soared 60%. In contrast, Compass shares fell 11.2% after announcing an all-stock acquisition of Anywhere Real Estate, which subsequently surged over 52%. Meanwhile, Kenvue dropped 4.6% on reports linking its Tylenol product to autism, highlighting significant idiosyncratic risk. Investors are now looking ahead to a week of key economic data, including the PCE inflation gauge and GDP figures, for further direction.